gestoden/etinilestradiol sandoz 0,075/0,020 mg tablete
sandoz d.d. - etinilestradiol, gestoden - tableta - etinilestradiol 0,02 mg / 1 tableta; gestoden 0,075 mg / 1 tableta - gestoden in etinilestradiol
gestoden/etinilestradiol sandoz 0,075/0,030 mg tablete
sandoz d.d. - etinilestradiol, gestoden - tableta - etinilestradiol 0,03 mg / 1 tableta; gestoden 0,075 mg / 1 tableta - gestoden in etinilestradiol
nacrez 75 mikrogramov filmsko obložene tablete
teva pharma b.v. - dezogestrel - filmsko obložena tableta - dezogestrel 75 µg / 1 tableta - dezogestrel
primolut nor 5 mg tablete
bayer d.o.o. - noretisteronacetat - tableta - noretisteronacetat 5 mg / 1 tableta - noretisteron
sildenafil mylan 50 mg filmsko obložene tablete
mylan s.a.s. - sildenafil - filmsko obložena tableta - sildenafil 50 mg / 1 tableta - sildenafil
sildenafil mylan 100 mg filmsko obložene tablete
mylan s.a.s. - sildenafil - filmsko obložena tableta - sildenafil 100 mg / 1 tableta - sildenafil
sildenafil stada 20 mg filmsko obložene tablete
stada arzneimittel ag - sildenafil - filmsko obložena tableta - sildenafil 20 mg / 1 tableta - sildenafil
werrca 3 mg/0,03 mg filmsko obložene tablete
gedeon richter plc. - drospirenon; etinilestradiol - filmsko obložena tableta - drospirenon 3 mg / 1 tableta etinilestradiol0,03 mg / 1 tableta; etinilestradiol 0,03 mg / 1 tableta - drospirenon in etinilestradiol
adcirca (previously tadalafil lilly)
eli lilly nederland b.v. - tadalafil - hipertenzija, pljučnica - urološki - adultstreatment of pulmonary arterial hypertension (pah) classified as who functional class ii and iii, to improve exercise capacity (see section 5. učinkovitost so pokazali pri idiopatskem pah (ipah) in pri pah, povezani s kolagensko vaskularno boleznijo. paediatric populationtreatment of paediatric patients aged 2 years and above with pulmonary arterial hypertension (pah) classified as who functional class ii and iii.
adempas
bayer ag - riociguat - hipertenzija, pljučnica - antihipertenzivi za pljučno arterijsko hipertenzijo - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. učinkovitosti je bil prikazan v pah prebivalstva, vključno z aetiologies z idiopatsko ali dedne pah ali pah, povezanih z vezivnega tkiva bolezni. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.